Testicular cancer is the most common malignancy among men between 14 and 44 years of
age, and its incidence has risen over the past two decades in Western countries. Both …

OBJECTIVES: The first consensus report presented by the European Germ Cell Cancer
Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many …

Context This is an update of the previous European Association of Urology testis cancer
guidelines published in 2011, which included major changes in the diagnosis and treatment …

Purpose: Testis cancer is the most common solid malignancy in young males. The purpose
of this guideline is to provide a useful reference on the effective evidence-based treatment of …

Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

Germ cell tumours (GCT) represent a rare malignancy affecting mostly Caucasian males
aged between 15 and 40 years. Among these young men, testicular GCT (TGCT) is the most …

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor
Markers in Adult Males With Germ Cell T Page 1 American Society of Clinical Oncology Clinical …

Purpose Initial results of a randomized trial comparing carboplatin with radiotherapy (RT) as
adjuvant treatment for stage I seminoma found carboplatin had a noninferior relapse-free …

Testicular cancer represents the most curable solid tumor, with a 10-year survival rate of
more than 95%. Given the young average age at diagnosis, it is estimated that effective …

Testicular germ-cell tumours (TGCTs) represent the model of a curable malignancy;
sensitive tumour markers, accurate prognostic classification, logical series of management …